|
| |
| | | 63277 | | 29.01.2014 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 11.99. | | | | 11.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Lucentis | Injektionslösung zur intravitrealen Anwendung in Fertigspritze | Injektionslösung zur intravitrealen Injektion in Fertigspritze (Ranibizumab 10 mg/ml) | S01LA04 | |
|
|
|
